International Review of Ophthalmology

Previous Articles     Next Articles

Application of botulinum toxin type A in ophthalmology

SU Han, FU Jing   

  1. Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology & Visual Science, Beijing 100730, China
  • Received:2018-08-13 Online:2018-12-22 Published:2018-12-22
  • Contact: FU Jing, Email: fu_jing@126.com
  • Supported by:

    High Level Health Technical Talent Training Program of Beijing Municipal Health Bureau(2015-3-023);Capital Health Development Project-Major Project, Beijing Municipal Bureau of Health(SF-2018-1-2051)

Abstract:

Since the report of the utilization of botulinum toxin type A (BTA) in treatment of strabismus in the 1970s, there were countless attempts and extensive applications of BTA in the treatment field of ophthalmic diseases such as strabismus, blepharospasm, eyelid retraction, entropion, lacrimal hypersecretion, nystagmus, due to its less trauma and side effects. Especially in the field of concomitant strabismus, it is a research hotspot. The efficacy  of BTA  in children's concomitant strabismus is still controversial. Complications are uncommon and are mostly transient, often occurring in relation to the position, dose and technique of injection. (Int Rev Ophthalmol, 2018, 42: 381-387)